Literature DB >> 21864589

Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.

Anurag Sharma1, Dinesh S Bangari, Sai V Vemula, Suresh K Mittal.   

Abstract

The state of vector genome in transduced cells influences the duration of transgene expression and can be a safety concern if it gets integrated randomly into the host genome. Although human adenovirus (Ad) serotype 5 (HAd5) mainly persists in a linear episomal form, information regarding the state of bovine Ad serotype 3 (BAd3) and porcine Ad serotype 3 (PAd3) vector genomes in human and nonhuman cells is currently unknown. To address this issue, MDA-MB-231 (human), MDBK (bovine), PK-15 (porcine), MT1A2 (mouse) and NIH-3T3 (mouse) cell lines were infected with replication-defective BAd3, PAd3 or HAd5 vectors carrying the green fluorescent protein (GFP) gene. The persistence and the state of vector genome were assessed by quantitative real-time PCR and Southern blot hybridization, respectively. Levels of transgene and Ad gene expressions were quantified using real-time RT-PCR. Persistence of BAd3 or PAd3 vectors was comparable to that of HAd5 vector. Only the linear episomal form of the vector genome was observed with each vector. In addition, expression levels of transgene as well as viral genes by all three vectors were comparable and correlated with their transduction levels in each cell type. These results indicate comparable biologic behavior of BAd3, PAd3 and HAd5 vectors in cell culture.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864589      PMCID: PMC3197224          DOI: 10.1016/j.virusres.2011.08.002

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  29 in total

1.  High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation.

Authors:  M Zeng; G J Cerniglia; S L Eck; C W Stevens
Journal:  Hum Gene Ther       Date:  1997-06-10       Impact factor: 5.695

2.  Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines.

Authors:  Alberto L van Olphen; Suresh K Tikoo; Suresh K Mittal
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

3.  Porcine adenovirus-3 as a helper-dependent expression vector.

Authors:  P Seshidhar Reddy; Neeraja Idamakanti; Lorne A Babiuk; Majid Mehtali; Suresh K Tikoo
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

Review 4.  Production of adenovirus vectors and their use as a delivery system for influenza vaccines.

Authors:  Sai V Vemula; Suresh K Mittal
Journal:  Expert Opin Biol Ther       Date:  2010-10       Impact factor: 4.388

5.  The structure of adenovirus type 12 DNA integration sites in the hamster cell genome.

Authors:  M Knoblauch; J Schröer; B Schmitz; W Doerfler
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Aseem Pandey; Harm HogenEsch; Suresh K Mittal
Journal:  Virology       Date:  2009-02-10       Impact factor: 3.616

Review 7.  Episomal vectors for gene therapy.

Authors:  Anja Ehrhardt; Rudolf Haase; Aloys Schepers; Manuel J Deutsch; Hans Joachim Lipps; Armin Baiker
Journal:  Curr Gene Ther       Date:  2008-06       Impact factor: 4.391

8.  Multiple copies of human adenovirus 12 genomes are integrated in virus-induced hamster tumors.

Authors:  M R Green; J K Mackey; M Green
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

Review 9.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

10.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

View more
  3 in total

Review 1.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

Review 2.  Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases.

Authors:  Marwa Alhashimi; Ahmed Elkashif; Ekramy E Sayedahmed; Suresh K Mittal
Journal:  Viruses       Date:  2021-07-29       Impact factor: 5.048

3.  A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose.

Authors:  Ekramy E Sayedahmed; Ahmed O Hassan; Rashmi Kumari; Weiping Cao; Shivaprakash Gangappa; Ian York; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-17       Impact factor: 6.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.